Iambic Therapeutics
Iambic Therapeutics is seeking a Machine Learning Scientist to research and develop post‑training methods for its multimodal transformer model, Enchant, aimed at advancing AI‑driven drug discovery. The role involves designing and evaluating fine‑tuning, reinforcement learning, and other optimization strategies, building scalable training infrastructure, and collaborating with cross‑functional teams to translate models into practical therapeutic tools.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2020
Iambic Therapeutics is a biotech company applying an AI-driven platform — including its Enchant and NeuralPLexer technologies — to tackle the most challenging design problems in drug discovery and address unmet patient needs. Its high-throughput experimental platform converts novel molecular designs into biological insights, enabling faster development of potential best-in-class and first-in-class medicines. Iambic maintains a proprietary clinical pipeline targeting cancers such as HER2-driven tumors and breast cancer, and pursues collaborations with pharmaceutical partners, including Bayer, to advance AI-driven drug discovery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Iambic Therapeutics.
Iambic Therapeutics didn’t post a salary, so this is our estimate from similar listings.
16% below the average for this role